Literature DB >> 7584555

Secretoneurin: a new peptide in the human enteric nervous system.

G Schürmann1, A E Bishop, P Facer, U Eder, R Fischer-Colbrie, H Winkler, J M Polak.   

Abstract

Secretoneurin is a functional neuropeptide derived from secretogranin II (chromogranin C). This proprotein is processed to varying degrees in neuroendocrine tissues. In the present study we established by gel filtration high performance liquid chromatography that in human intestinal wall and mucosa an antiserum against secretoneurin detects as the major immunoreactive moiety the free peptide secretoneurin. In the mucosa some larger immunoreactive peptides were also present, however, a significant amount of the intact proprotein secretogranin II could not be detected. By immunohistochemistry we studied the distribution of secretoneurin within the gut. Antibodies to protein gene product 9.5 and chromogranin A were used to identify all neurons and endocrine cells, respectively, whilst those to the peptides substance P, CGRP and somatostatin were used for the further characterization of individual secretoneurin-positive structures. Secretoneurin immunoreactivity was found in nerve fibres in all layers of the gut wall. In both myenteric and submucous plexuses, nerve fibres and the majority of ganglion cells were secretoneurin-immunoreactive. In the mucosa, some secretoneurin-positive nerve processes ran parallel to the basal membrane of epithelial cells, occasionally invading the epithelial layer. Secretoneurin immunoreactivity was found in endocrine cells, mostly D cells, in the following regions in descending order of density: stomach/duodenum; rectum; colon; ileum. Thus, secretoneurin is a new major peptide within the human enteric neuroendocrine system. Its presence in abundant myenteric ganglion cells may imply a role in the modulation of gastrointestinal motility. The chemotactic properties of secretoneurin and its possible localization in sensory fibres suggest that this peptide may be involved in the genesis of intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7584555     DOI: 10.1007/BF01464781

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  41 in total

Review 1.  Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.

Authors:  B Wiedenmann; W B Huttner
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

2.  Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system.

Authors:  G Schürmann; M Betzler; H J Buhr
Journal:  Eur J Surg Oncol       Date:  1990-08       Impact factor: 4.424

3.  Immunological characterization of secretory proteins of chromaffin granules: chromogranins A, chromogranins B, and enkephalin-containing peptides.

Authors:  R Fischer-Colbrie; I Frischenschlager
Journal:  J Neurochem       Date:  1985-06       Impact factor: 5.372

4.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

5.  Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C).

Authors:  A Saria; J Troger; R Kirchmair; R Fischer-Colbrie; R Hogue-Angeletti; H Winkler
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

6.  Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation.

Authors:  H Blaschko; R S Comline; F H Schneider; M Silver; A D Smith
Journal:  Nature       Date:  1967-07-01       Impact factor: 49.962

7.  The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5).

Authors:  S Gulbenkian; J Wharton; J M Polak
Journal:  J Auton Nerv Syst       Date:  1987-03

8.  Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C).

Authors:  R Kirchmair; R Hogue-Angeletti; J Gutierrez; R Fischer-Colbrie; H Winkler
Journal:  Neuroscience       Date:  1993-03       Impact factor: 3.590

9.  Immunodetection of secretogranin II in animal and human tissues by new monoclonal antibodies.

Authors:  M Pelagi; A Zanini; A Gasparri; L Ermellino; A M Giudici; S Ferrero; A G Siccardi; R Buffa
Journal:  Regul Pept       Date:  1992-06-11

Review 10.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

View more
  5 in total

1.  Obstructive ileus of large bowel is associated with low tissue levels of neuropeptides in prestenotic bowel segment.

Authors:  R Prommegger; J Marksteiner; G Wetscher; J Tschmelitsch; U Eder; R Fischer-Colbrie; A Saria; E Bodner
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

2.  Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis.

Authors:  Michael Wagner; Mats Stridsberg; Christer G B Peterson; Per Sangfelt; Maria Lampinen; Marie Carlson
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

3.  New insights into the understanding of gastrointestinal dysmotility.

Authors:  Bodil Ohlsson; Sabina Janciauskiene
Journal:  Drug Target Insights       Date:  2007-09-25

Review 4.  Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice.

Authors:  Laura Francesca Pisani; Gian Eugenio Tontini; Beatrice Marinoni; Vincenzo Villanacci; Barbara Bruni; Maurizio Vecchi; Luca Pastorelli
Journal:  Front Med (Lausanne)       Date:  2017-05-10

5.  Defining the transcriptomic landscape of the developing enteric nervous system and its cellular environment.

Authors:  Sweta Roy-Carson; Kevin Natukunda; Hsien-Chao Chou; Narinder Pal; Caitlin Farris; Stephan Q Schneider; Julie A Kuhlman
Journal:  BMC Genomics       Date:  2017-04-12       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.